GlcNAc kinase Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-O-Methyl-N-acetyl-D-glucosamine | 94825-74-8 | sc-202886A sc-202886 sc-202886B | 1 mg 5 mg 10 mg | $102.00 $245.00 $388.00 | 2 | |
3-O-Methyl-N-acetyl-D-glucosamine is a notable substrate for GlcNAc kinase, characterized by its ability to undergo phosphorylation, which is crucial for glycosylation processes. Its structural features facilitate specific enzyme-substrate interactions, enhancing reaction specificity and kinetics. The compound's unique methyl and acetyl groups influence its solubility and reactivity, allowing it to participate in diverse metabolic pathways and cellular signaling mechanisms. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
Acetazolamide inhibits GlcNAc kinase by interfering with the enzyme's catalytic activity, leading to reduced GlcNAc phosphorylation and glycosylation processes within cells. | ||||||
BAY 61-3606 | sc-507485 | 2 mg | $345.00 | 1 | ||
BAY 61-3606 inhibits GlcNAc kinase by competing with ATP for binding to the enzyme's active site, disrupting GlcNAc phosphorylation and glycosylation events. | ||||||
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine | 105650-23-5 | sc-208996B sc-208996C sc-208996 sc-208996A sc-208996D sc-208996E | 1 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $118.00 $203.00 $322.00 $634.00 $1076.00 $1733.00 | 38 | |
This compound acts as a GlcNAc kinase inhibitor by interacting with the enzyme′s active site, hindering the phosphorylation of GlcNAc, and disrupting glycosylation events within cells. | ||||||
3-Bromo-7-nitroindazole | 74209-34-0 | sc-200347 sc-200347A | 5 mg 25 mg | $20.00 $26.00 | 1 | |
3-Bromo-7-nitroindazole inhibits GlcNAc kinase through a mechanism that involves binding to the enzyme's active site, blocking GlcNAc phosphorylation, and impeding glycosylation pathways. | ||||||
BRD 7389 | 376382-11-5 | sc-361129 sc-361129A | 10 mg 50 mg | $181.00 $714.00 | ||
BRD7389 functions as a GlcNAc kinase inhibitor by binding to the enzyme's ATP-binding site, thereby inhibiting GlcNAc phosphorylation and interfering with glycosylation events in cells. | ||||||
2-Amino-2-norbornanecarboxylic acid | 20448-79-7 | sc-237901 | 100 mg | $182.00 | 1 | |
BCH inhibits GlcNAc kinase by serving as a competitive inhibitor of the enzyme's substrate, GlcNAc. It hinders the phosphorylation of GlcNAc, leading to impaired glycosylation processes within cells. | ||||||